Jump Financial, LLC

Position in OCUL — Ocular Therapeutix, Inc

CIK 1831577 Chicago, IL

Position in OCUL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,446,201

+$42,676 QoQ

Shares Held

350,937

-12.7% QoQ

Ownership

0.160%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#61

of 257 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names. OCUL ranks #40 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	306,330	$24,288,904
2	VKTX	Viking Therapeutics, Inc.	579,882	$22,621,196
3	XENE	Xenon Pharmaceuticals Inc.	260,730	$15,737,662
4	CRSP	CRISPR Therapeutics AG	277,952	$15,159,500
5	BMRN	Biomarin Pharmaceutical Inc	245,390	$14,041,214
6	SRPT	Sarepta Therapeutics, Inc.	679,445	$12,209,626
7	REGN	Regeneron Pharmaceuticals, Inc.	16,242	$10,127,536
8	RARE	Ultragenyx Pharmaceutical Inc.	286,952	$9,581,327

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,446,201	350,937	-12.7%	Shares	Defined	2026-08-13
2026-03-31	$3,403,525	401,833	+131.2%	Shares	Defined	2026-05-14
2025-12-31	$2,109,847	173,793	+179.3%	Shares	Defined	2026-02-17
2025-09-30	$727,398	62,224	-49.6%	Shares	Defined	2026-08-13
2024-06-30	$844,343	123,442	+185.0%	Shares	Defined	2024-11-14
2024-03-31	$394,202	43,319	-80.3%	Shares	Sole	2024-05-13
2023-06-30	$1,136,748	220,300	+96.7%	Shares	Sole	2024-10-21
2023-03-31	$590,240	112,000	+85.7%	Shares	Sole	2024-10-21
2021-09-30	$603,000	60,300	-22.0%	Shares	Sole	2021-11-12
2021-06-30	$1,096,269	77,311	+377.2%	Shares	Sole	2021-08-13
2020-09-30	$123,282	16,200	—	Shares	Sole	2020-11-13
No filing history on record for this holder in this stock.